Mirabella Financial Services LLP Immunovant, Inc. Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
BUY
$14.2 - $23.75 $987,936 - $1.65 Million
69,573 New
69,573 $1.32 Million
Q4 2020

Feb 16, 2021
SELL
$36.36 - $52.71 $516,384 - $748,587
-14,202 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$22.61 - $38.9 $321,107 - $552,457
14,202 New
14,202 $500,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email